Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder

Journal of Child and Adolescent Psychiatric Nursing

Volumn 12, Issue 4, 1999, Pages 168-172

  Scahill, Lawrence ^a   Barloon, Linda ^b   Farkas, Lesley ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Childrms Mercy Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; GUANFACINE;

ATTENTION DEFICIT DISORDER; CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; DRUG POTENTIATION; HUMAN; LOCUS CERULEUS; PREFRONTAL CORTEX; REVIEW; TIC; TREATMENT OUTCOME;

ADRENERGIC ALPHA-AGONISTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLONIDINE; GUANFACINE; HUMANS; LOCUS COERULEUS; PREFRONTAL CORTEX; RECEPTORS, ADRENERGIC, ALPHA-2; TICS; TREATMENT OUTCOME;

EID: 0033206223     PISSN: 10736077     EISSN: 17446171     Source Type: Journal    
DOI: 10.1111/j.1744-6171.1999.tb00065.x     Document Type: Article

References (30)

1. Arnsten, A.F.T., Steere, J.C, & Hunt, R.D. (1996). The contribution of alpha-2 noradrenergic mechanisms to prefrontal cortical cognitive functions: Potential significance to attention-deficit hyperactivity disorder. Archives of General Psychiatry, 53,448-455.
2. Balldin, J., Berggren, U., Eriksson, E., Lindstedt, G., & Sundkler, A. (1993). Guanfacine as an alpha-2-agonist inducer of growth hormone secretion. A comparison with clonidine. Psychoneuroendocrin-ology, 18(1), 45-55.
3. Barkley, R.A., McMurray, MB., Edelbrock, C.S., & Robbins, K. (1992). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics, 86,184-192.
4. Barrickman, L.L., Perry, P.J., Allen, A.J., Kuperman, S., Arndt, S.V., Herrmann, K.J., & Schumacher, E. (1995). Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34,649-657.
5. Biederman, J., Baldessarini, R.J., Wright, V, Knee, D., & Harmatz, J.S. (1989). A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy Journal of the American Academy of Child and Adolescent Psychiatry, 28,777-784.
6. Borcherding, B.G., Keysor, C.S., Rappoport, J.L., Elia, J., & Amass,J. (1990). Motor/visual tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Research, 33,83-94.
7. Buitelaar, J. K., Van der Gaag, R.J., Swaab-Bameveld, H., & Kuiper, M. (1996). Pindolol and methlyphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. Journal of Child Psychology and Psychiatry, 37,587-595.
8. Castellanos, F.X., Giedd, J.N., Elia,J.', Marsh, W., Ritchie, G.F., Hamburger, S.D., & Rappoport, J.L. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 589-596.
9. Chappell, P.B.,Riddle, M.A., Scahill, L" Lynch, K.A., Schultz, R., Arnsten, A., Leckman, J.F., & Cohen, D.J. (1995). Guanfacine treatment of comorbid attention deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 34,1140-1146.
10. Conner, DF. (1993). Beta blockers for aggression: A review of the pediatric experience. Journal of Child and Adolescent Psychopluirmacology, 3,99 -114.
11. Conners, C.K., Casat, CD., Gualtieri, C.T., Weller, E., Reader, M., Reiss, A., Welter, R.A., Khayrallah, M., & Ascher, J. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatnj, 34,1314-132
12. Dulcan, M., & Work Group. (1997). Practice parameters for the assessment and treatment of children, adolescents, and adults with attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36(Suppl.) 85S-121S.
13. Feigin, A., Kurlan, R., McDermott, M.P, Beach, J., Dimitsapulos, T, Brower, C.A., Chapieski, L., Trinidad, K., Como, P., & Jankovic, J. (19%). A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology, 46,965-968.
14. Gadow, K.D., Sverd, J., Sprafkin, J Nolan, E.E., & Ezor, N. (1995). Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archives of General Psychiatry, 52,444-455.
15. Golden, G.S. (1974). Gilles de la Tourette's syndrome following methylphenidate administration. Developmental Medicine and Child Neurology, 16,76 -78.
16. Greenhill, L.L. (1995). Attention-deficit hyperactivity disorder: The stimulants. Child and Adolescent Psychiatric Clinics of North America, 4,123 -168.
17. Horrigan, J.P., & Barnhill, L.J. (1995). Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. Journal of Child and Adolescent Psychopharmacology, 5,215-223.
18. Horrigan, J.P., & Barnhill, L.J. (1998). Does guanfacine trigger mania in children? Journal of Child and Adolescent Psychopharmacology, 8,149 -150.
19. Hunt, R.D., Arnsten, A.F.T., & Asbell, M.D. (1995). An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34,50-54.
20. Hunt,' R.D., Minderaa, R.B., & Cohen, D.J. (1985). Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. Journal of the American Academy of Child and Adolescent Psychiatry, 24,617-629.
21. Kurlan, R. (1997). Treatment of tics. Neurologic Clinics, 15,403-410.
22. Leckman, J.F., Hardin, M.T., Riddle, M.A., Stevenson, J., Ort, S.I., & Cohen, D.J. (1991). Clonidine treatment of Gilles de la Tourette syndrome. Archives of General Psychiatry, 48,324-328.
23. Lipkin, P.H., Goldstein, I.J., & Adesman, A.R. (1994). Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Archives of Pediatric and Adolescent Medicine, 148,859-861.
24. Lowe, T.L., Cohen, D.J., Detlor, J., Kremenizer, M.W., & Shaywitz, B.A. (1982). Stimulant medications precipitate Tourette's syndrome. JAMA, 247,1168-1169.
25. Newcom, J.H., Schulz, K., Harrison, M., DeBellis, M.D., Udarbe, J.K., & Halperin, J.M. (1998). Alpha-2 adrenergic agonists, neurochemistry, efficacy, and clinical guidelines for use in children. Pediatric Clinics of North America, 45,1099-1122.
26. Popper, C.W. (1995). Combining methylphenidate and clonidine: Pharmacologic questions and new reports about sudden death. Journal of Child and Adolescent Psychopharmacology, 5,157-166.
27. Riddle, M.A., Geller, B., & Ryan, N. (1993). Another sudden death in a child treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 792 - 797.
28. Riddle, M.A., Lynch, K.A., Scahill, L" deVries, A., Cohen, D.J., & Leckman, J.F. (1995). Methylphenidate discontinuation during long-term treatment of children with Tourette's disorder and attention deficit hyperactivity disorder: A pilot study Journal of Child and Adolescent Psychopharmacology, 5,205-214.
29. Scahill, L. (1997). Psychopharmacology for children. In N.L Keltner & D.G. Folks (Eds.), Psychotropic drugs (pp. 350-373), St. Louis: Mosby.
30. Singer, H.S., Brown, J., Quaskey, S., Rosenberg, LA., Mellits, E.D., & Denckla, M.B. (1995). The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics, 95, 74-81.